Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thalassemia major between liver and heart: Where we are now.
Dessì C, Leoni G, Moi P, Danjou F, Follesa I, Foschini ML, Morittu M, Zappu A, Defraia E, Bina P, Cunico A, Civolani A, Podda RA, Origa R. Dessì C, et al. Among authors: defraia e. Blood Cells Mol Dis. 2015 Jun;55(1):82-8. doi: 10.1016/j.bcmd.2015.03.010. Epub 2015 Apr 6. Blood Cells Mol Dis. 2015. PMID: 25976473
Thalassemia Major: Who Is Afraid of Serum Ferritin below 500 μg/l?
Pinna F, Carta R, Morittu M, Dessì C, Moi P, Leoni G, Foschini ML, Defraia E, Zappu A, Origa R. Pinna F, et al. Among authors: defraia e. Acta Haematol. 2015;134(3):183-4. doi: 10.1159/000371866. Epub 2015 May 27. Acta Haematol. 2015. PMID: 26022742 No abstract available.
A decisional algorithm to start iron chelation in patients with beta thalassemia.
Danjou F, Cabantchik ZI, Origa R, Moi P, Marcias M, Barella S, Defraia E, Dessì C, Foschini ML, Giagu N, Leoni GB, Morittu M, Galanello R. Danjou F, et al. Among authors: defraia e. Haematologica. 2014 Mar;99(3):e38-40. doi: 10.3324/haematol.2013.098202. Haematologica. 2014. PMID: 24598857 Free PMC article. No abstract available.
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave.
Indini A, Pinotti G, Artioli F, Aschele C, Bernardi D, Butera A, Defraia E, Fasola G, Gamucci T, Giordano M, Iaria A, Leo S, Ribecco AS, Rossetti R, Savastano C, Schena M, Silva RR, Grossi F, Blasi L. Indini A, et al. Among authors: defraia e. Eur J Cancer. 2021 May;148:112-116. doi: 10.1016/j.ejca.2021.01.040. Epub 2021 Feb 25. Eur J Cancer. 2021. PMID: 33743478 Free PMC article.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
De Giorgi U, Cartenì G, Giannarelli D, Basso U, Galli L, Cortesi E, Caserta C, Pignata S, Sabbatini R, Bearz A, Buti S, Lo Re G, Berruti A, Bracarda S, Cognetti F, Rastelli F, Fornarini G, Porta C, Turci D, Sternberg CN, Procopio G; Italian Nivolumab Renal Cell Cancer Early Access Program Group. De Giorgi U, et al. BJU Int. 2019 Jan;123(1):98-105. doi: 10.1111/bju.14461. Epub 2018 Jul 23. BJU Int. 2019. PMID: 29956884 Free article.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
68 results